Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
1
Bearish filings
5
Named actors
4
Disclosed $ (bull / bear)
$0 / $1.7M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-06-25 | Officer (via Morgan Stanley Smith Barney LLC Executive Financial Services) XICHEN LIN | filed notice to sell | $1.7M | SEC ↗ |
| 2026-05-07 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-03-30 | Chief Medical Officer Blai Coll | adopted a selling plan | — | SEC ↗ |
| 2026-03-29 | Chief Development Officer Ashley Hall | adopted a selling plan | — | SEC ↗ |
| 2026-03-26 | Chief Scientific Officer Xichen Lin | adopted a selling plan | — | SEC ↗ |
| 2025-08-18 | 5%+ holder (13G) BIOTECHNOLOGY VALUE FUND L P | disclosed a passive stake (13G) | — | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals